Anti-Human MUC13 Therapeutic Antibody (TCC56)

This anti-Mucin 13 monoclonal antbody is a newly developed antibody targeting pancreatic ductal adenocarcinoma cells, which may be promising anticancer agents to alleviate the adverse effects of chemotherapy in cancer therapy.
Supplier Creative Biolabs
Product # TAB-440MZ
Pricing Inquiry
Applications Cyt, FC, IP
Host Mouse
Target MUC13 (Mucin13)
Feedback